“Revolutionary Breakthrough: Supplement Endorsed by Leading Doctors for Cannabis Dependency”

While it’s true that no medications are currently FDA approved for Cannabis Use Disorder (CUD), and behavioral therapy remains the primary treatment, recent studies are shedding light on promising alternatives. Dr. Frances Levin, a respected figure in clinical psychiatry at Columbia University Medical Center, highlighted these possibilities during a presentation on advancements in substance use disorder treatment.

Traditionally, managing withdrawal symptoms has been a key aspect of CUD treatment. Yet, Dr. Levin’s research challenges the effectiveness of this approach in promoting cannabis abstinence. Despite the lack of evidence supporting withdrawal symptom management, there’s hope in the form of N-acetylcysteine (NAC), an antioxidant.

NAC operates differently from traditional medications by restoring normal levels of the neurotransmitter glutamate, associated with compulsive drug-seeking behaviors, rather than directly targeting CBD receptors. While it’s not a universal solution, data suggests that when combined with behavioral therapy, NAC has shown promising results, particularly in adolescents and young adults up to 21 years old.

Enter N-acetylcysteine (NAC), the game-changer in combating drug craving. Backed by rigorous research, a systematic review of seven randomized controlled trials involving 245 participants across various substance use disorders, including cannabis, demonstrates its effectiveness. With a dosage range of 1200 to 3600 mg/day, the results speak volumes: a significant clinical difference in drug craving, indicating a substantial effect size (Hedges’ g = 0.94).

National Library of Medicine https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993450/

What it does

Vejovis Maximum Support/NAC stimulates glutathione biosynthesis, promotes detoxification, and acts directly as a scavenger of free radicals.
Vejovis Maximum Support/NAC provides certain noticeable benefits in attenuating substance craving and may help alleviate depressive symptoms and withdrawal syndrome.

How it works

The time it takes to experience benefits from Vejovis Maximum Support/NAC depends on various factors, including the dosage and baseline glutathione levels, which can be influenced by your lifestyle and overall health. Most of the evidence suggests that the benefits of Vejovis Maximum Support/NAC become apparent within 3 to 4 weeks of daily supplementation.

How to take

Take one to two Vejovis Maximum Support/NAC capsules daily., or as directed by a physician

Benefits

Approximately 85% of individuals with an SUD/Substance Use Disorder, do not seek treatment for it, and those who do are older, have a longer history of use, have more severe dependence, and have sought treatment numerous times before. By the time most people seek treatment, years of chronic substance use have likely led to significant brain-related adaptations. Individuals with SUDs often indicate that their substance use began as a pleasurable activity—the effects of the drug were enjoyable and they were motivated to use it again. With repeated substance use, they may begin to develop a stronger urge to use the drug, driven not necessarily by a desire for pleasure, but by compulsion.
Numerous neural adaptations underlie the transition from “liking” a substance to engaging in the compulsive use that is characteristic of an SUD. For example, repeated use of an addictive substance may result in excess glutamate in the nucleus accumbens an area of the brain that plays a critical role in motivation and learning. As a result, it is has been proposed that pharmacotherapies that help correct glutamate dysregulation may be effective in promoting abstinence or preventing relapse to a substance
Vejovis Maximum NAC may reverse the neural dysfunction seen in SUDs. As an OTC antioxidant that impacts glutamatergic functioning in the brain, NAC has long been used to treat acetaminophen overdose; however, in recent years, researchers have begun to tap its potential for treating substance use and psychiatric disorders. NAC is thought to upregulate the glutamate transporter (GLT-1) that removes excess glutamate from the nucleus accumbens. Several published reviews provide more in-depth information about the neurobiology of Vejovis Maximum Support/NAC